Triplet Induction + 1 or 2-Drug Maintenance

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Near Add Your Location

Sorting 370 by

Smilow Cancer Hospital
Torrington, CT
  • Accepting patients
Southeast Cancer Center
Southeast Health
Cape Girardeau, MO
  • Accepting patients
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, MO
  • Accepting patients
Roy and Patricia Disney Family Cancer Center
Providence Saint Joseph Medical Center
Burbank, CA
  • Accepting patients
SIH Cancer Institute
Carterville, IL
  • Accepting patients
Providence Oncology and Hematology - Eastside
Providence Cancer Institute Franz Clinic
Portland, OR
  • Accepting patients
Carle (Effingham)
Effingham, IL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.